PRMT5 is overexpressed in a variety of human cancers including leukemia and lymphoma7, gastric cancer8, breast cancer9, colorectal cancer10 and glioblastoma11,12, which is correlated with a poor prognosis13,14. This evidence concerns the gene PRMT5 and cancer.